Literature DB >> 27108197

Mast cell inflammasome activity in the meninges regulates EAE disease severity.

Abigail E Russi1, Margaret E Walker-Caulfield2, Melissa A Brown3.   

Abstract

Inflammasomes are multiprotein complexes that assemble in response to microbial and other danger signals and regulate the secretion of biologically active IL-1β and IL-18. Although they are important in protective immunity against bacterial, viral and parasitic infections, aberrant inflammasome activity promotes chronic inflammation associated with autoimmune disease. Inflammasomes have been described in many immune cells, but the majority of studies have focused on their activity in macrophages. Here we discuss an important role for mast cell-inflammasome activity in EAE, the rodent model of multiple sclerosis, a CNS demyelinating disease. We review our evidence that mast cells in the meninges, tissues that surround the brain and spinal cord, interact with infiltrating myelin-specific T cells in early disease. This interaction elicits IL-1β expression by mast cells, which in turn, promotes GM-CSF expression by T cells. In view of the essential role that GM-CSF plays in T cell encephalitogenicity, we propose this mast cell-T cell crosstalk in the meninges is critical for EAE disease development.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CNS demyelinating disease; EAE; GM-CSF; IL-1β; Inflammasome; Mast cells; Meninges; Multiple sclerosis; T cell pathogenicity

Mesh:

Substances:

Year:  2016        PMID: 27108197     DOI: 10.1016/j.clim.2016.04.009

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  15 in total

Review 1.  New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Authors:  Chih-Chung Lin; Brian T Edelson
Journal:  J Immunol       Date:  2017-06-15       Impact factor: 5.422

Review 2.  Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

Authors:  Daniel Elieh-Ali-Komi; Yonghao Cao
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

Review 3.  Neuroinflammation, neurodegeneration and regeneration in multiple sclerosis: intercorrelated manifestations of the immune response.

Authors:  Tatiana Koudriavtseva; Caterina Mainero
Journal:  Neural Regen Res       Date:  2016-11       Impact factor: 5.135

Review 4.  Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.

Authors:  Duraisamy Kempuraj; Ramasamy Thangavel; Govindhasamy P Selvakumar; Smita Zaheer; Mohammad E Ahmed; Sudhanshu P Raikwar; Haris Zahoor; Daniyal Saeed; Prashant A Natteru; Shankar Iyer; Asgar Zaheer
Journal:  Front Cell Neurosci       Date:  2017-07-24       Impact factor: 5.505

Review 5.  Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.

Authors:  Elizabeth A Mills; Ali Mirza; Yang Mao-Draayer
Journal:  Front Neurol       Date:  2017-03-29       Impact factor: 4.003

Review 6.  An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.

Authors:  Stephen D Skaper; Laura Facci; Morena Zusso; Pietro Giusti
Journal:  Front Cell Neurosci       Date:  2018-03-21       Impact factor: 5.505

Review 7.  Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review.

Authors:  Yue Lang; Fengna Chu; Donghui Shen; Weiguanliu Zhang; Chao Zheng; Jie Zhu; Li Cui
Journal:  Mediators Inflamm       Date:  2018-04-17       Impact factor: 4.711

8.  Prostaglandin D2 signaling in dendritic cells is critical for the development of EAE.

Authors:  Jian Zheng; Alan Sariol; David Meyerholz; Qinran Zhang; Juan E Abrahante Lloréns; Shuh Narumiya; Stanley Perlman
Journal:  J Autoimmun       Date:  2020-07-02       Impact factor: 7.094

Review 9.  Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease.

Authors:  Julia Derk; Hannah E Jones; Christina Como; Bradley Pawlikowski; Julie A Siegenthaler
Journal:  Front Cell Neurosci       Date:  2021-07-01       Impact factor: 5.505

10.  Significant Contribution of Mouse Mast Cell Protease 4 in Early Phases of Experimental Autoimmune Encephalomyelitis.

Authors:  Louisane Desbiens; Catherine Lapointe; Marjan Gharagozloo; Shaimaa Mahmoud; Gunnar Pejler; Denis Gris; Pedro D'Orléans-Juste
Journal:  Mediators Inflamm       Date:  2016-08-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.